The Clinical Imaging Scientific Director for Oncology owns the strategy and execution of sophisticated early- and late-phase oncology imaging in clinical trials where imaging plays a key role, with a special focus on PET and CT. The role champions the development of imaging endpoints and biomarkers, drives the scientific imaging aspects of oncology clinical studies, and leads tumor response assessment. As an independent imaging scientific leader, this position serves on cross-functional program teams with Regeneron clinical and preclinical colleagues and external academic and industry partners. The role offers opportunities to develop innovative imaging endpoints and biomarkers in support of clinical development and new treatment options for patients. The position develops fit-for-purpose imaging biomarker strategies and collaborates with research, clinical imaging, and the oncology therapeutic area to advance the clinical pipeline. It leads the design and implementation of multimodality imaging measures as endpoints, advises clinical teams on imaging strategy and study design, and oversees imaging components in partnership with Clinical Imaging Operations and imaging contract research organizations. The role also serves as Study Scientific Director for trials qualifying and using novel imaging biomarkers and leads regulatory interactions related to imaging endpoints, procedures, and biomarker development studies. The role is based in Tarrytown, New York; Cambridge, Massachusetts; or Warren, New Jersey, four days per week, with remote work also considered for the right candidate.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree